Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice
Authors:
- 1 March 2022
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 102 (3) , 281-289
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Downstream Signaling Pathways in Mouse Adipose Tissues Following Acute In Vivo Administration of Fibroblast Growth Factor 21PLOS ONE, 2013
- The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 DiabetesCell Metabolism, 2013
- Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stressBMC Gastroenterology, 2013
- A general introduction to the biochemistry of mitochondrial fatty acid β‐oxidationJournal of Inherited Metabolic Disease, 2010
- Tissue-specific Expression of βKlotho and Fibroblast Growth Factor (FGF) Receptor Isoforms Determines Metabolic Activity of FGF19 and FGF21Journal of Biological Chemistry, 2007
- Endocrine Regulation of the Fasting Response by PPARα-Mediated Induction of Fibroblast Growth Factor 21Cell Metabolism, 2007
- Mechanisms linking obesity to insulin resistance and type 2 diabetesNature, 2006
- Forced expression of hepatocyte-specific fibroblast growth factor 21 delays initiation of chemically induced hepatocarcinogenesisMolecular Carcinogenesis, 2006
- FGF-21 as a novel metabolic regulatorJournal of Clinical Investigation, 2005
- Systemic low-grade inflammation is related to both circulating and adipose tissue TNFα, leptin and IL-6 levels in obese womenInternational Journal of Obesity, 2004